Insightec Reaches 10,000 EMEA Patients With MRgFUS
HAIFA, Israel and FRANKFURT, Germany — September 8, 2026 Insightec announced that more than 10,000 patients across Europe, the...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
HAIFA, Israel and FRANKFURT, Germany — September 8, 2026 Insightec announced that more than 10,000 patients across Europe, the...
Bedford, Massachusetts, USA September 3, 2026 Stoke Therapeutics and Biogen have presented new long-term clinical data supporting the potential...
OSAKA, Japan and CAMBRIDGE, Mass., September 2, 2026 Ono Pharmaceutical Co., Ltd. has entered into a drug discovery partnership...
MINNEAPOLIS, Minnesota, Aug. 31, 2026 The American Academy of Neurology (AAN) and the American Headache Society (AHS) have issued...
TOKYO and CAMBRIDGE, Mass., August 31, 2026 Eisai and Biogen announced that Canada’s Drug Agency (CDA-AMC) has issued a...
SAN DIEGO, U.S, Aug 28, 2026 Acadia Pharmaceuticals Inc. announced that the European Commission (EC) has granted marketing authorization...
INDIANAPOLIS, U.S., Aug 28, 2026 Roche has received U.S. FDA clearance for Elecsys® Phospho-Tau (217P) Plasma (pTau217), a blood-based...
Milan, Italy – August 28, 2026 Zambon announced that the European Commission has granted marketing authorization for Hopledo® (modified-release...
RALEIGH, N.C. – August 27, 2026 Slate Medicines Inc. announced that the first participant has been dosed in its...
Secaucus, New Jersey, August 24, 2026 Quest Diagnostics announced new developments in its Quest AD-Detect® blood-testing portfolio, expanding access...
